Compare NeoGenomics Inc. Common Stock (NEO) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NeoGenomics Inc. Common Stock vs Vir Biotechnology Inc. Common Stock — how do they compare? NeoGenomics Inc. Common Stock trades at $17 (market cap $2.17B), while Vir Biotechnology Inc. Common Stock trades at $10.5 (market cap $1.76B). The key difference: NeoGenomics Inc. Common Stock is the larger of the two by market cap, and Vir Biotechnology Inc. Common Stock is more actively traded (2,764,948 versus 1,615,943). Which is the better fit depends on your goals — on Pluang, investors hold NeoGenomics Inc. Common Stock for 0 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| NEO | VIR | |
|---|---|---|
Market Cap | $2.17B | $1.76B |
Volume | 1,615,943 | 2,764,948 |
Sector | Health | Health |
52-Week High | $19.91 | $11.78 |
52-Week Low | $7.19 | $5.12 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $2.47B | $1.32B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About NeoGenomics Inc. Common Stock
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →About Vir Biotechnology Inc. Common Stock
Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →
